Search

everythinglearnresearchcommunity

for

Search:↓

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The HCR gene contributes to psoriasis risk.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Many patients on new leukemia drugs had mild to moderate skin reactions.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Adding a second method to PROTACs could improve cancer treatment.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Clascoterone is safe for the heart, even at high doses.

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.